BioGaia

118.70 SEK

+0.68%

Less than 1K followers

BIOG B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioGaia

P/E

Median 2019-2025

EV/S

Median 2019-2025

EV/EBIT

Median 2019-2025

Dividend yield

Median 2019-2025

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)84.90107.40103.6083.57101.20111.90106.20
Shares86.789.3101.0101.0101.0101.2101.2
Market cap7,359.19,588.110,461.58,439.110,219.411,320.010,743.4
Enterprise value7,145.38,120.38,976.86,950.78,675.210,096.09,942.1
EV/S9.310.911.46.36.77.16.5
EV/EBITDA27.732.731.918.018.520.222.7
EV/EBIT29.535.635.419.219.623.824.1
P/E39.353.353.322.628.032.232.3
P/B14.495.495.574.285.036.578.17
P/S9.612.813.37.67.98.07.0
Dividend yield0.9 %0.6 %0.7 %3.5 %6.8 %6.2 %3.8 %
Equity ratio76.3 %91.3 %88.2 %89.1 %87.0 %84.8 %82.3 %
Gearing ratio-------